|
|
Feature Story: |
New Expert Article: EU Hearing Device Market Faces Mounting Pricing Pressure |
The European market for hearing devices has experienced significant growth in recent years. In particular, the total number of hearing aids sold in France, Germany, and the United Kingdom has grown dramatically. In 2015, the market was valued at just over €7.2 billion. While the overall market is experiencing moderate growth, there are two opposing forces at play. First, there have been decreases across the board in the average sales price (ASP) of a hearing device. This has had a limiting effect on the market. Second, there has been an increase in...
Click here to Read on MedDeviceOnline.com
|
|
|
|
Report Areas
Ultrasound Imaging
Medical Imaging
Breast Imaging
PACS
Diagnostics
Patient Monitoring
Diabetes |
|
Patient monitoring and diagnostic equipment will be in high demand in the U.S. due to steadily increasing cases of chronic illness in the U.S. population, including heart disease, obesity, diabetes, high cholesterol and high blood pressure among other conditions. This will facilitate increased investment into capital equipment and disposables, despite hospital budget constraints, reimbursement cuts and consolidation within industry group purchasing organizations. Moreover, the ease of use, accuracy and affordability of these devices will become an important factor in product development within the home patient monitoring device market. read more} |
Report Categories
Endoscopic Devices
Gastrointestinal Devices
Video, Hi-Tech, and Image Guided Systems
Laparoscopy
Soft Tissue Repair PACS
Canadian Endoscopy
Wound & Tissue Care
|
|
According to our new series of reports on the U.S. gastrointestinal device market the average selling prices (ASPs) are expected to remain under significant pressure due to purchasing consolidation as hospitals acquire outpatient facilities. In addition, the expanding reach of group purchasing organizations together with reimbursement cuts across the gastrointestinal (GI) device space has negatively impacted growth of the market. However, the rising prevalence of GI related conditions, coupled with the tremendous adoption of colorectal cancer screening programs is projected to result in growth in the overall market. read more} |
|
|
|
|
|
|
|